Joseph Fleishaker, Ph.D., has been named vice president, Clinical Pharmacology and Exploratory Development, Astellas. Dr. Fleishaker will be located at Astellas’ global headquarters for the Medical and Development organization in Northbrook, IL, and will report to Dr. Bernie Zeiher, president, Development.
 
Dr. Fleishaker will oversee clinical pharmacology and exploratory development, which includes all clinical pharmacology, pharmacokinetics, modeling and simulation support for early as well as late-stage development programs. As a member of the Development Leadership Team, he will play a role in leading this functional area to fully characterize clinical candidates.
 
Dr. Fleishaker joined the company in 2012, and most recently served as vice president and global therapeutic head of Neuroscience and previously as executive director and project lead of Development, leading the CNS/Pain therapeutic area.
 
“Joe brings a wealth of experience to this important position at Astellas, including more than 25 years in the pharmaceutical industry leading clinical pharmacology and translational medicine research as well as a preclinical drug metabolism group,” said Dr. Zeiher. “We are pleased Joe has accepted this role to help our organization continue to advance our capabilities in clinical pharmacology.”